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Speciﬁc effects of KChIP3/calsenilin/DREAM, but not KChIPs 1, 2 and 4, on
calcium signalling and regulated secretion in PC12 cells
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The KChIPs (K
+ channel-interacting proteins) are members
of the NCS (neuronal calcium sensor) protein family of Ca
2+-
binding proteins. It is unclear to what extent the KChIPs have
distinctfunctionsalthoughtheyallinteractwithKv4K
+ channels.
KChIP3 has also been shown to repress transcription of speciﬁc
genes via binding to DRE (downstream regulatory element)
motifs and all KChIPs may share this function. In the present
study, we have compared the function of isoforms of the four
KChIPs. KChIPs 1–4 were found to stimulate the trafﬁc of
Kv4.2 channels to the plasma membrane. KChIP3 expression
in PC12 cells resulted in an increase in exocytosis evoked by
activation of purinergic receptors. In contrast, KChIPs 1, 2 and 4,
although expressed to the same extent, had no effect on secretion.
In addition, KChIP3 but not KChIPs 1, 2 and 4 modiﬁed the
ATP-induced Ca
2+ signal resulting in a delay in recovery after
the peak Ca
2+ elevation and also speciﬁcally resulted in down-
regulationoftheNa
+/Ca
2+ exchangerNCX3,whichcouldexplain
the effects on the Ca
2+ signal and secretion. Regulation of NCX3
by KChIP3 has been shown to occur via its DREAM (DRE
antagonist modulator) function [Gomez-Villafuertes, Torres,
Barrio, Savignac, Gabellini, Rizzato, Pintado, Gutierrez-Adan,
Mellstrom, Carafoli and Naranjo (2005) J. Neurosci. 25, 10822–
10830] suggesting that this activity might depend on the cellular
contextofexpressionofthevariousKChIPs.Theseresultsreveala
new role for KChIP3 in the regulation of Ca
2+-regulated secretion
and also suggest that the functions of each of the KChIPs may be
more specialized than previously appreciated.
Key words: calcium, EF-hand, exocytosis, Na
+/Ca
2+ exchanger,
neuronal calcium sensor (NCS) protein, neurotransmitter
release.
INTRODUCTION
The transduction of intracellular Ca
2+ signals into physiological
responses is mediated by Ca
2+ sensor proteins that interact with
speciﬁc target proteins to modify their function [1]. Many of
these Ca
2+ sensors bind Ca
2+ via EF-hand domains. One such
familyofproteinsaretheNCS(neuronalcalciumsensor)proteins
consisting of NCS-1, neurocalcin δ, hippocalcin, VILIPs (visin-
like proteins) 1–3, recoverin, GCAPs (GC-activating proteins)
1–3 and the KChIPs (K
+ channel-interacting proteins) 1–4 [2,3].
Certain NCS proteins are expressed only in the retina (recoverin
and GCAPs) [4], whereas others are expressed predominantly
in the brain or, in the case of NCS-1, in a wide range of
neuronal and non-neuronal cell types. Mammals have at least 26
different NCS proteins generated by the expression of 14 genes
and by differential splicing [5]. The distinct cellular expression
patterns of the NCS proteins, their distinct cellular and molecular
properties and in particular their speciﬁc target proteins, allows
them to regulate a diverse range of neuronal functions in a
non-redundant manner [2]. The latter point is supported by the
presenceofclearphenotypesinorganismswithgeneticdisruption
of the expression of only a single NCS protein [2]. However, it is
still unclear why so many different NCS proteins are required.
In mammals, KChIP proteins are encoded by four genes
(KChIPs 1–4) each of which can give rise to multiple splice
variants [5]. The KChIPs were so named based on their discovery
as proteins that can interact with the pore-forming subunits of
K
+ channels of the Kv4 family [6–8]. The physiological signiﬁ-
cance of KChIPs 2 and 3 in the heart and the brain has been
established from the study of mouse knockouts [9–11]. All
KChIP proteins examined so far are able to become constitutive
subunits of Kv4 channels [12,13], stimulate Kv4 channel trafﬁc
to the plasma membrane [14,15] and modify the gating properties
of the channels [6]. Different KChIPs or their isoforms have,
however,subtlydifferenteffectsonKv4channelgatingproperties
[8,16,17]. KChIP3 was independently discovered in two other
contexts. First, as calsenilin, a protein able to interact with
the presenilins and affect the processing of amyloid precursor
protein [18]. Secondly, as DREAM (downstream-regulatory-
element-antagonist modulator), based on its ability to act as a
repressor of transcription when it is Ca
2+-free but not Ca
2+-
bound [19]. In addition to the common interaction with Kv4
channels, isoforms of all four KChIPs have been shown to have
DREAMactivity[20]andatleastKChIP4,inadditiontoKChIP3,
can also interact with presenilins [7]. The KChIPs may not all
have overlapping functions, as knockout of KChIPs 2 and 3
leads to non-compensated phenotypes [9–11]. However, the non-
redundancy may be due to differential expression of KChIPs in
different cell types. The requirement for multiple KChIPs may
relate to speciﬁc neuronal expression patterns [21,22] allowing
differences in ﬁne tuning of Kv4 channel function, for example,
in different neuronal cell types. Nevertheless, it is still unclear
to what extent the KChIPs have fully overlapping or distinct
functional roles. In the present study we have set out to compare
the functions of representative isoforms of each of the four
KChIPs and this has revealed a speciﬁc effect of KChIP3/
Abbreviations used: AM, acetoxymethyl ester; DMEM, Dulbecco’s modiﬁed Eagle’s medium; DREAM, downstream-regulatory-element-antagonist
modulator; ECFP, enhanced cyan ﬂuorescent protein; EGFP, enhanced green ﬂuorescent protein; EYFP, enhanced yellow ﬂuorescent protein; ER,
endoplasmic reticulum; FCS, foetal calf serum; GCAP, GC-activating protein; GH, growth hormone; KChIP, K+ channel-interacting protein; NCS, neuronal
calcium sensor; NCX, Na+/Ca2+ exchanger; PBT, PBS containing 0.1% Triton X-100 and 0.3% BSA; rhod, Rhodamine.
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calsenilin/DREAMinmodifyingagonist-evokedCa
2+ signalsand
in enhancing secretion from PC12 cells.
MATERIALS AND METHODS
Plasmids
Plasmid encoding presenilin-1–EGFP (where EGFP is enhanced
green ﬂuorescent protein) [23] was a gift from Dr Christian
Haass (Adolf-Butenandt-Institute, Department of Biochemistry,
Ludwig-Maximilians-University,Munich,Germany).TheKChIP
splice variants used in the present study were KChIP1.2,
KChIP2.3, KChIP3.1 and KChIP4.1 but these will be referred to
henceforth as KChIPs 1–4. All KChIP isoforms used are human,
with the GenBank® accession numbers as follows: DQ148477
(1.2), DQ148481 (2.3), DQ148485 (3.1) and DQ148487 (4.1).
The KChIP1–ECFP (where ECFP is enhanced cyan ﬂuorescent
protein), ECFP–Kv4.2 plasmids have been described previously
[15,24]. The KChIP2–ECFP construct was made by inserting the
KChIP2sequenceintothepECFP-N1vector(Clontech)following
ampliﬁcation from an existing KChIP2-pcDNA construct (kindly
provided by Dr Robert B¨ ahring, Zentrum f¨ ur Molekulare
Neurobiologie, Hamburg, Germany) with the following primers
(the endonuclease sites are underlined): sense, 5
 -ACTC-
AGATCTCAGGATGCGGGGCCAGGGCCGC-3
  (BglII) and
antisense, 5
 -TACCGTCGACTGGATGACATTGTCAAAGAG-
3
  (SalI). The KChIP3–ECFP construct was made by inserting
the KChIP3 sequence into the pECFP-N1 vector following
ampliﬁcation from an existing KChIP3–EYFP (where EYFP is
enhancedyellowﬂuorescentprotein)constructwiththefollowing
primers: sense, 5
 -ACTCAGATCTCAGGATGCAGCCGGC-
TAAGGAA-3
  (BglII) and antisense, 5
 -TGCAGAATTCCG-
ATGACATTCTCAAACAGC-3
  (EcoRI). The KChIP4–ECFP
construct was made by insertion of the KChIP4 sequence into
the pECFP-N1 vector following ampliﬁcation from a KChIP4
cDNA clone (OriGene), with the following primers: sense, 5
 -
ACTCAGATCTCAGGATGAATGTGAGGAGGGTG-3
  (BglII)
and antisense, 5
 -TACCGTCGACTGAATCACATTTTCAAA-
GAG-3
  (SalI). The pcDNA-KChIP3 construct was made by the
insertion of the KChIP3 sequence into the pcDNA3.1 (+) vector
(Invitrogen), following ampliﬁcation from KChIP3–EYFP with
the following primers: sense, 5
 -TTCGAATTCAGGATGCAG-
CCGGCTAAGGAA-3
  (EcoRI) and antisense, 5
 -CAAC-
GCGGCCGCTAGATGACATTCTCAAACAGC-3
  (NotI). The
FLAG-tagged KChIP constructs were made by insertion into
the pFLAG-CMV-4 expression vector (Sigma), following
ampliﬁcation from existing constructs. For FLAG–KChIP1,
the sense primer was 5
 -GCTTGCGGCCGCGAGGATGGGG-
GCCGTCATGGGC-3
  (NotI) and the antisense primer was 5
 -
TATCAGATCTATTTACATGACATTTTGAAACAG-3
  (BglII).
For FLAG–KChIP2, the sense primer used was 5
 -GCTT-
GCGGCCGCGAGGATGCGGGGCCAGGGCCGC-3
  (NotI)
and the antisense primer was 5
 -TATCAGATCTATCTAGATGA-
CATTGACAAAGAG-3
  (BglII). For FLAG–KChIP3, the sense
primer used was 5
 -GCTTGCGGCCGCGAGGATGCAGCCG-
GCTAAGGAA-3
  (NotI) and the antisense primer was 5
 -TATC-
AGATCTCCCTAGATGACATTCTCAAACAGC-3
  (BglII). For
FLAG–KChIP4, the sense primer used was 5
 -GCTTGCG-
GCCGCGAGGATGAATGTGAGGGTG-3
  (NotI) and the
antisense primer was 5
 -TATCAGATCTATTTAAATCACA-
TTTTCAAAGAG-3
  (BglII).
All primers used in PCR ampliﬁcation were produced by
Genosys Biotechnologies and the sequences of all of the
constructs were conﬁrmed with sequencing by DBS Genomics.
Culture and transfection of HeLa and COS-7 cells
HeLa and COS-7 cells were grown in DMEM (Dulbecco’s
modiﬁed Eagle’s medium; Gibco) containing 5% FCS (foetal
calf serum; Gibco) and 1% non-essential amino acids (Gibco)
and maintained in 75 cm
2 ﬂasks at 37◦C in an atmosphere of
5% CO2. At 16–24 h prior to transfection, cells were seeded
on to glass coverslips in a 24-well plate at 40000 cells/well or
100000 cells/well of a 6-well plate. Cells were then transfected
at approaching 50% conﬂuency using 100 μl of transfection
reactionmixture.Thetransfectionmixtypicallycontained1 μgof
plasmid DNA (2 μg for double transfections) and 3 μl( p e rμgo f
p l a s m i dD N A )o fF u G E N E
TM (Roche) and was made up to
100 μl with DMEM. The transfection reaction mixture was
incubated at room temperature (24◦C) for 30 min before being
added dropwise to the cells. Cells were then maintained at
37◦C for an additional 48 h before being used in experi-
ments.
Culture and transfection of PC12 cells
PC12 cells were grown in suspension in RPMI 1640 me-
dium (Gibco) containing 5% (v/v) FCS, 10% (v/v) horse serum
(Gibco), 100 units/ml penicillin and 0.1 mg/ml streptomycin
(Sigma) at 37◦C in an atmosphere of 5% CO2. At 16–24 h
before transfection, freshly trypsinized cells were plated on to
collagen-coated glass coverslips in a 24-well plate at a density of
200000 cells/well or 350000 cells/well for larger coverslips.
Cells were then transfected using 100 μl of transfection
reaction mixture consisting of 1 μgo fp l a s m i dD N A ,3 μlo f
Lipofectamine
TM 2000 transfection reagent (Invitrogen) per μg
of plasmid DNA and made up to 100 μl in opti-MEM (Gibco)
The transfection mixture was incubated at room temperature for
30 min before being added dropwise to the cells. The cells were
then incubated for 4–6 h at 37◦C with the transfection reaction
mixture before removing the transfection reaction mixture and
replacing with growth medium. Cells were then maintained at
37◦C, 5% CO2 for an additional 48 h before being used in
experiments.
Imaging of cells and immunoﬂuorescence staining
Forimagingoftransfectedcellsexpressingﬂuorescentconstructs,
the cells were washed twice in PBS and ﬁxed in PBS containing
4% formaldehyde for 30 min. Cells were then washed in
PBS before air-drying the coverslips and mounted on to glass
slides using anti-fade Vectashield (Vector Laboratories). For
immunostainingofcellsattachedtocoverslips,thesewerewashed
twiceinPBSbeforeﬁxationinPBScontaining4%formaldehyde
for 30 min. The cells were incubated in PBT (PBS containing
0.1% Triton X-100 and 0.3% BSA) for 30 min. The PBT was
removed, replaced by the primary antibody diluted in PBT
and the coverslips were incubated for 1–2 h. For staining
of Kv4.2 channels after transfection of COS-7 cells, rabbit
anti-Kv4.2 antiserum (Exalpha Biologicals) was used at a
1:500 dilution. For staining of endogenous NCX2 (Na
+/Ca
2+
exchanger 2) and NCX3 proteins, PC12 cells were incubated
with a mouse monoclonal anti-NCX2 antibody at 1:50 or
a rabbit polyclonal anti-NCX3 antibody at 1:50. Anti-NCX2
and anti-NCX3 antibodies were a gift from Professor Kenneth
Philipson, (Cardiovascular Research Laboratories, UCLA School
of Medicine, Los Angeles, CA, U.S.A.). The cells were
washed three times in PBT followed by incubation with an
appropriate species-speciﬁc Dylight-649-conjugated secondary
antibody (1:200; Pierce) for 30 min prior to air drying and
mounting of coverslips on to glass slides.
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Confocal laser scanning microscopy
For confocal laser scanning microscopy, either a Leica AOBS
microscope system (Leica) or a Leica TCS-SP-MP microscope
was used to examine transfected cells using an optimal pin
hole of 1 airy unit and a 63× water-immersion objective with
a 1.2 numerical aperture. For imaging of live cells, cells were
maintained in Krebs–Ringer buffer [20 mM Hepes (pH 7.4),
145 mM NaCl, 10 mM glucose, 5 mM KCl, 3 mM CaCl2,
1.3 mM MgCl2 and 1.2 mM NaH2PO4]. For imaging ECFP-
taggedconstructs,cellswereexcitedat430 nmandlightcollected
at 460–510 nm. EGFP was imaged using excitation at 488 nm
with collection at 500–550 nm.For dualimaging ofECFP-tagged
KChIP proteins and Kv4.2 or endogenous NCX proteins labelled
with Dylight-649, cells were excited with 405 nm and 633 nm
lasers and light was collected at 465–500 nm (ECFP) and 680–
750 nm (Dylight 649). Images were exported as Tiff ﬁles and
c o m p i l e di nC o r e l D r a w .
For quantiﬁcation of total ECFP ﬂuorescence or anti-NCX2
and anti-NCX3 ﬂuorescence staining in PC12 cells, Leica-
Lite post-capture analysis software (Leica Microsystems) was
used to draw regions of interest around the perimeter of
cells. The ﬂuorescence intensity of anti-NCX2 or anti-NCX3
staining in KChIP–ECFP-expressing cells was directly compared
with control non-transfected cells on the same coverslips. For
comparison of expression levels of KChIPs 1–4, transfected cells
were examined for all constructs on the same day using identical
imagingconditionswiththesamesettingsformagniﬁcation,laser
power and gain.
Western blotting
CellstobeusedforWesternblottingwerewashedinPBSfollowed
by lysis in 100 μl of Laemmli buffer (Sigma). Cell samples
were then boiled for 10 min. Typically, 20 μl of sample was
separated on SDS/PAGE (10% gel) before overnight transfer
on to nitrocellulose. Nitrocellulose blots were washed twice with
PBS for 15 min before blocking with 3% (w/v) non-fat dried
skimmed milk in PBS for 45 min. The primary antibody was
added at the appropriate dilution (anti-GFP at 1:5000) in 3%
(w/v) non-fat dried skimmed milk in PBS and was incubated
for 1 h at room temperature or overnight at 4◦C. The antibody
solution was then removed and the blot was washed three times
in PBS. The blot was then incubated with the appropriate HRP
(horseradishperoxidase)-conjugatedsecondaryantibody(Sigma)
diluted 1:400 in 3% (w/v) non-fat dried skimmed milk and
0.5% Tween in PBS for 1 h. The blot was then washed once in
PBS containing 0.5% Tween, washed three times in PBS, once
in 0.3 M NaCl in PBS for 30 min and once in distilled water
for 15 min. The blot was then developed using ECL® (enhanced
chemiluminescence) reagents (Amersham).
Assay of GH (growth hormone) secretion from PC12 cells
For an assay of GH secretion from transfected cells [25,26],
freshly trypsinized PC12 cells were plated out on to poly-D
lysine-coated 24-well plates (VWR International) at a density of
350000 cells/well at 16–24 h prior to transfection. Cells
were transfected using 100 μl of transfection reaction mixture
consisting of 1 μg of control/test plasmid DNA, 1 μg of human
GH plasmid and 3 μl of Lipofectamine
TM 2000 transfection
reagent (Invitrogen) per μgo fp l a s m i dD N A ,m a d eu pt o1 0 0μl
in opti-MEM (Gibco). The transfection mixture was incubated
at room temperature for 30 min before being added dropwise
to the cells. The cells were then incubated for 4–6 h at 37◦C
with the transfection reaction mixture before removing the
transfection reaction mixture and replacing with growth medium
supplemented with 10 μMC d C l 2. Cells were then maintained at
37◦C, 5% CO2 for a further 48 h before use in experiments. The
secretion assay was performed on either permeabilized or intact
cells depending upon the experiment. In the case of the former,
cellswerewashedoncewithKGEPbuffer[20 mMPipes(pH 6.5),
139 mMKglutamate,5 mMEGTA,2 mMATPand2 mMMgCl2]
before permeabilization with KGEP buffer containing 20 μM
digitoninfor6 min.Cellswerestimulatedbyadditionof300 μlof
KGEP buffer containing no added CaCl2 or with CaCl2 added to
give a calculated free Ca
2+ concentration of 10 μM and incubated
for 15 min. For experiments on intact cells, cells were washed
with Krebs–Ringer buffer and then stimulated by the addition of
300 μl of buffer with either 0 or 300 μM ATP and incubated for
15 min at room temperature. After stimulation, supernatants were
collectedandstoredbeforelysisoftheremainingadherentcellsin
distilled water containing 0.5% (v/v) Triton X-100 (300 μl/well
for 15 min) to give corresponding samples containing unsecreted
GH. GH was assayed following the manufacturer’s instructions
in the hGH (human GH) ELISA kit (Roche Diagnostics). The
levels of GH were calculated and secreted GH was expressed as
a percentage of the total GH for each well.
Imaging of intracellular [Ca2+] in PC12 cells
ForanalysisofchangesintheintracellularfreeCa
2+ concentration
([Ca
2+]i) in PC12 cells, the cells were plated on to collagen-
coated glass coverslips (350000 cells/well) and transfected
with 2 μgo fc o n t r o lp l a s m i do r2 μg of test plasmid using
Lipofectamine
TM 2000 reagent (Invitrogen) according to the
manufacturer’s protocol. At 48 h after transfection, the cells were
washed in Krebs–Ringer buffer and then incubated with 1 μMX -
rhod-1 AM (rhod is Rhodamine and AM is acetoxymethyl ester;
Molecular Probes) in Krebs–Ringer buffer for 30 min at room
temperature. Cells were washed in Krebs–Ringer buffer before
imaging using laser-scanning confocal microscopy. An ECFP
image was taken prior to each experiment to allow distinction
betweentransfectedanduntransfectedcells.X-rhod-1wasimaged
using the Leica CS-SP-MP microscope with excitation at 543 nm
and light collection at 600–650 nm. The X-rhod-1 ﬂuorescence
was diffusely and uniformly distributed, suggesting cytosolic
localization of the probe. Before and after the application of
300 μM ATP as an agonist, the ﬂuorescence of X-rhod-1 was
monitored and the ﬂuorescence values for the cells was expressed
after normalization to the initial ﬂuorescence level for that cell
(F/Fo).
RESULTS
Plasmids were constructed encoding four KChIP isoforms
(KChIP1.2, KChIP2.3, KChIP3.1 and KChIP4.1) with each
KChIP prepared as a C-terminal ECFP- or N-terminal FLAG-
tagged construct. Since the terminology used for KChIP isoforms
in the literature is inconsistent we have deﬁned these by their
accession number in the Materials and methods section but will
refer to them henceforth as KChIPs 1–4 for simplicity. In order to
validate the functionality of the constructs and to conﬁrm that the
ﬂuorescently tagged KChIPs behaved as expected for the wild-
type proteins, we assessed their expression in cell lines and their
ability to stimulate the trafﬁc of Kv4.2 to the plasma membrane
based on imaging of expressed Kv4.2 [15]. In initial studies using
HeLa cells, we successfully found cells expressing KChIPs 1, 2
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Figure1 Co-expressionofKChIPs1–4withKv4.2inCOS-7cellsstimulates
trafﬁc of Kv4.2 to the plasma membrane
(A) COS-7 cells were transfected to express KChIPs 1–4 as ECFP-tagged constructs and
expression of the proteins was detected by Western blotting with an anti-GFP antibody.
(B) COS-7 cells were transfected to express Kv4.2 and 48h after transfection the cells were
ﬁxed and channel localization was detected by immunostaining with an anti-Kv4.2 antibody.
(C–F)COS-7cellsweretransfectedtoco-expressKv4.2,oneoftheKChIP–ECFPs,asindicated
and channel localization was detected by immunostaining with anti-Kv4.2. The colour overlays
show the KChIP–ECFPs in green and Kv4.2 in red, with co-localization seen in yellow. In all
cases, trafﬁc of the Kv4.2 to the plasma membrane was evident (arrowheads) along with KChIP
localization to the plasma membrane. The scale bar represents 10μm.
or 4 but found poor survival of cells expressing KChIP3–ECFP,
consistentwiththereportedapoptoticeffectofKChIP3expression
in HeLa cells [27]. In contrast, all four KChIPs were ex-
pressed to the same extent in COS-7 cells (Figure 1A) and did
not appear to affect cell survival. The four KChIPs expressed
as ECFP fusion proteins had differing intracellular localizations
consistent with previous results [14] with KChIP1 present on
intracellular punctate structures as seen previously [15], KChIP2
being plasma-membrane-associated and KChIPs 3 and 4 being
diffusely distributed throughout the cells (results not shown). As
reported previously [15] Kv4.2, when expressed alone, trafﬁcked
poorly to the plasma membrane and accumulated in the Golgi
complex (Figure 1B). In cells co-transfected to express Kv4.2
along with one of the KChIP proteins, all of the KChIPs co-
localized with Kv4.2 and importantly all four KChIPs stimulated
the trafﬁc of the channel to the plasma membrane with all
of the KChIPs also being associated with the plasma membrane
(Figure 1), demonstrating a similar functional ability of the four
KChIP isoforms studied to interact with Kv4.2 as seen in other
studies [6,14].
PC12 cells are a neuronal/neuroendocrine model cell line
widely used in the study of Ca
2+ signalling and Ca
2+-triggered
secretion [28]. Overexpression of NCS-1 in these cells leads to
increased secretion in response to agonist stimulation [29] via
activation of phosphatidylinositol-4 kinase-IIIβ [30,31]. Since
KChIP3 has previously been shown to modify Ca
2+ signalling
in other cell types [32,33] we aimed to examine the effect of
overexpression of the KChIPs in PC12 cells using regulated
secretion as an initial functional read out. All four KChIPs
were expressed in PC12 cells following transfection (Figure 2A)
although they had distinct intracellular localizations similar to
that seen in COS-7 cells (Figure 2B). KChIP1 showed a punctate
pattern of localization, KChIP2 was primarily associated with the
plasma membrane and KChIPs 3 and 4 were diffusely distributed
in the cytosol and the nucleus. From the Western blot (Figure 2A)
analysis,thevariousKChIPsappearedtobeexpressedatdifferent
levels in PC12 cells. We observed, however, that the numbers of
cells expressing the constructs differed between the KChIPs. In
order to ensure that individual transfected cells expressed the
same levels of each of the KChIP–ECFPs we quantiﬁed
theaveragecellularﬂuorescenceintensityofeachoftheexpressed
ECFP constructs, taking into account total cellular ﬂuorescence
so that this would not be affected by differences in localization.
No differences were seen in overall cellular expression levels for
the four KChIPs (Figure 2C).
To probe the effect of KChIP overexpression on secretion, we
made use of a well-established assay in which cells were co-
transfected so that they expressed human GH as well as a test
protein of choice. This approach is used so that only secretion
from the small percentage (∼5%) of transfected cells can be
assayed. GH is not normally expressed by these cells but in
transfectedcellsispackagedintodensecoregranulesandsecreted
in response to Ca
2+ elevation [26,34]. This system was used to
demonstrate a stimulatory effect on regulated secretion due
to NCS-1 overexpression [29]. The PC12 cells were co-
transfected to express GH and each of the KChIPs as FLAG-
tagged constructs. GH secretion was assayed under basal
conditions and in response to activation of purinergic receptors
following addition of 300 μM ATP that primarily activates P2X
receptors to stimulate secretion in these cells [35,36]. None
of the KChIPs signiﬁcantly affected basal release of GH but
expression of FLAG–KChIP3 speciﬁcally increased the amount
of GH release due to ATP stimulation (Figure 3A). The FLAG
tag was at the N-terminus of the proteins where it would
prevent myristoylation of KChIP1 which is important for its
membrane targeting [24]. Therefore we also tested the effect of
transfection with untagged constructs in the pcDNA3 vector. In a
comparisonofKChIPs1and3itwasobservedthatagainKChIP3
expression increased ATP-stimulated GH release but KChIP1
did not (Figure 3B). These results also show that the effect of
KChIP3 was not affected by the presence of the FLAG tag. In
addition, expression of KChIP3 tagged at the C-terminus with
ECFP also increased GH release in response to ATP (see below).
The magnitude of the increase in stimulated GH release owing
to KChIP3 expression was similar to that previously seen with
NCS-1 overexpression [29].
The effect of KChIP3 on GH secretion in PC12 cells could
be due to a direct effect on the exocytotic machinery. If this
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Figure 2 Expression of KChIP–ECFPs in PC12 cells
(A) PC12 cells were transfected to express KChIPs 1–4 as ECFP-tagged constructs and expression of the proteins was detected by Western blotting with an anti-GFP antibody. (B) PC12 cells
were transfected to express KChIPs 1–4 as ECFP-tagged constructs and live cells were imaged 48h after transfection. KChIP1 was localized to punctate structures, whereas KChIP2 was found
predominantlyontheplasmamembraneandKChIPs3and4appearedtobemainlycytosolicandalsopresentinthenucleus.Thescalebarrepresents10μm.(C)Theaverageﬂuorescenceintensity
of cells expressing each of the four KChIPs (n=12–18) was determined under identical imaging conditions in order to compare expression levels.
was the case then secretion directly triggered by increasing Ca
2+
concentration to a ﬁxed level would also be affected by KChIP3
expression. Alternatively, the effect could result from alterations
in the Ca
2+ signal generated in response to ATP. This was tested
by examining the effect of KChIP3 on GH release from cells
permeabilizedwithdigitoninandchallengedwith0or10 μMfree
Ca
2+ [26]. In cells expressing ECFP-tagged KChIP3, GH release
was increased following ATP stimulation of intact cells as seen
above but unaffected in permeabilized cells (Figure 4) suggesting
an indirect effect of KChIP3 expression on exocytosis.
Overexpression of KChIP3 has been shown to result in an
increase in the Ca
2+ content of the ER (endoplasmic reticulum)
[33] and to reduce the expression of one of the three [37] plasma
membrane Na
+/Ca
2+ exchangers, NCX3 [32]. Therefore it is
possible that the effect of KChIP3 on GH secretion could have
been due to a modiﬁcation in the Ca
2+ signal following ATP
stimulation. To ﬁnd out whether this was the case, and if any
effect was speciﬁc for KChIP3, PC12 cells were transfected with
each of the KChIPs tagged with ECFP, the cells were loaded
with the calcium indicator X-rhod-1 and changes in [Ca
2+]i
in response to ATP were monitored [38]. Before and after
stimulation, cellular ﬂuorescence levels were monitored from
high-ECFP-expressing cells and adjacent control non-transfected
cells and the data for expressing and non-transfected cells on
the same coverslips were directly compared. Expression of ECFP
alonehadnoeffectonthe[Ca
2+]i changesduringATPstimulation
(results not shown). Expression of KChIPs 1–4 had no signiﬁcant
effect on the peak increase in [Ca
2+]i following ATP addition
(Figure 5). KChIPs 1, 2 and 4 had no detectable effect on any
other aspect of the Ca
2+ signal but KChIP3–ECFP resulted in
a signiﬁcantly elevated [Ca
2+]i during later times as the Ca
2+
concentration was slowly declining (Figure 5C).
KChIP3 is known to interact with presenilin-1 and -2 and
the presenilins have been shown to potentially affect [Ca
2+]i
through an effect on ER Ca
2+ by having a Ca
2+ leak function
[39]. Presenilins are widely expressed [40] including in PC12
cells and, therefore, it was possible that the effect of KChIP3 on
Ca
2+ signals and secretion could have been due to an interaction
with presenilin. To test this possibility we examined the effect of
expression on presenilin-1 itself on [Ca
2+]i and secretion and
its effect of the enhancement of secretion by KChIP3. Cells
weretransfected tooverexpresspresenilin-1usingapresenilin-1–
EGFP construct that has previously been shown to function like
the wild-type protein [23]. Expression of presenilin-1–EGFP did
not signiﬁcantly modify the Ca
2+ response to ATP stimulation
(Figure 6A). In addition, presenilin-1–EGFP expression did
not affect GH secretion (Figure 6B). We conﬁrmed that co-
transfection allowed the expression of both presenilin-1–EGFP
and KChIP3–ECFP (Figure 6C). Expression of presenilin-1–
EGFP had no effect on the stimulation of GH secretion due to
KChIP3 expression (Figure 6D). Therefore these results did not
supportaninteractionbetweenKChIP3andpresenilinunderlying
the effects on [Ca
2+]i and secretion. Similarly we did not see any
signiﬁcanteffectonGHsecretionortheenhancementofsecretion
by KChIP3 in PC12 cells transfected to express Kv4.2 channels
(results not shown).
An alternative explanation for the effect of KChIP3 expression
on reducing the decline of the Ca
2+ transient would be by down-
regulation of the NCX3 plasma membrane Na
+/Ca
2+ exchanger.
It has been shown that overexpression of wild-type or expression
of a Ca
2+-insensitive and thus activated mutant of KChIP3 in
SH-SY5Y cells results in suppression of transcription of NCX3
through DREAM activity, whereas other NCX transporters are
unaffected and expression of the mutant in cerebellar granule
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Figure 3 Expression of KChIP3, but none of the other KChIPs, increases
stimulated GH release from PC12 cells
(A) PC12 cells were transfected to express GH and each one of the KChIPs as N-terminally
FLAG-taggedconstructswiththeFLAGvectorwasusedasacontrol.At2daysaftertransfection
the cells were washed in Krebs–Ringer buffer and incubated with no additions (Basal) or with
300μM ATP for 15min. GH release was assayed and expressed as a percentage of the total
cellular GH levels (n=4). (B) PC12 cells were transfected to express GH and KChIPs 1 or 3
in pcDNA3 as untagged constructs with the pcDNA vector used as a control. At 2 days after
transfection, the cells were washed in Krebs–Ringer buffer and incubated with no additions
(Basal)orwith300μMATPfor15min.GHreleasewasassayedandexpressedasapercentage
of the total cellular GH levels (n=9).
cells results in a slowing of the recovery of the [Ca
2+]i following a
Ca
2+ transient [32]. To test whether the speciﬁc effect of KChIP3
expression in PC12 cells could be explained by a reduction in
NCX3 expression we used immunoﬂuorescence with speciﬁc
antisera to determine the expression levels of endogenous NCX3
and NCX2 as a control in transfected cells in comparison with
non-transfected cells on the same coverslips. No differences were
seen in NCX2 levels under any conditions (Figure 7). For NCX3,
nodifferenceswereobservedforcellsexpressingKChIPs1,2or4
but in the case of KChIP3 the ﬂuorescence intensity of expressing
cells was seen to be lower than that of adjacent non-trans-
fected cells (Figure 7A). Quantiﬁcation of the ﬂuorescence
indicated a speciﬁc reduction by KChIP3 of NCX3 levels in
transfected cells compared with non-transfected control cells
(Figure 7B).
DISCUSSION
From the study of the major known functions of the KChIPs no
indications have so far emerged to suggest that they have speciﬁc
physiological roles but rather have overlapping functions [41].
This is surprising given that the knockout mice that have been
studiedforeitherKChIP2orKChIP3haveobservablephenotypes
[9–11], indicating that the KChIPs cannot compensate for one
Figure 4 KChIP3–ECFP increases stimulated release of GH in intact cells,
but not in response to Ca2+ in permeabilized PC12 cells
(A) PC12 cells were transfected to express GH and KChIP3–ECFP with the ECFP vector used
as a control. At 2days after transfection, the cells were washed in Krebs–Ringer buffer and
incubated with no additions (Basal) or with 300μM ATP for 15min. GH release was assayed
and expressed as a percentage of the total cellular GH levels (n=12). (B) PC12 cells were
transfected to express GH and KChIP3–ECFP with the ECFP vector used as a control. At 2 days
after transfection the cells were washed, permeabilized with digitonin and incubated in the
presence of 0 or 10μMf r e eC a 2+ for 15min. GH release was assayed and expressed as a
percentage of the total cellular GH levels (n=6).
another. One possibility is that KChIPs are non-redundant due
to cell-type-speciﬁc patterns of expression [21,22]. Nevertheless,
although the multiple KChIP isoforms have a common EF-hand-
containing domain they have distinct N-termini suggesting the
possibility of distinct interactions and functions. In the present
study we have demonstrated a distinct effect of expression of
KChIP3, compared with isoforms of KChIPs 1, 2 and 4, on Ca
2+
responsestostimulationinPC12cellsthatmaybeduetoaspeciﬁc
effectontheexpressionoftheNCX3plasmamembraneNa
+/Ca
2+
exchanger and we have also shown that this leads to speciﬁc
physiological consequences in which KChIP3 but not KChIPs 1,
2 and 4 can enhance stimulus-evoked secretion.
PreviousworkhasshowneffectsofKChIP3onCa
2+ signalling.
In one case this was attributed to an increased ﬁlling of ER
Ca
2+ stores [33]. The plasma membrane Na
+/Ca
2+ exchangers
play crucial roles in the recovery of [Ca
2+]i following transient
elevations [42]. Expression of an EF-hand mutant of KChIP3
(Ca
2+-independent and thereby locked in an activating state) also
resulted in a slowing of the recovery from a Ca
2+ elevation in
cerebellar granule cells [32]. This was attributed to a reduction
in the levels of expression of the plasma membrane Na
+/Ca
2+
exchanger NCX3 due to a direct repression of its transcription
without effects on other exchangers NCX1 and NCX2. The latter
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Figure 5 Expression of KChIP3, but not KChIPs 1, 2 or 4 delays the decline of intracellular free Ca2+ concentration from the peak after stimulation
with ATP
PC12 cells were transfected to express KChIPs 1–4 as ECFP-tagged constructs and 48h after transfection were loaded with X-rhod-1 AM and then live cells were imaged. An ECFP image was taken
toallowidentiﬁcationoftransfectedandnon-transfectedcellsandthenX-rhod-1ﬂuorescencewasmonitoredbeforestimulationandafterstimulationbyperfusionwith300μMATP.ImagesofECFP
and X-rhod-1 before and at the peak after stimulation are shown. After completion of the experiment, average values were collected for whole cell ﬂuorescence for transfected and adjacent control
cells. Fluorescence values were normalized to the initial ﬂuorescence for each cell and the results are shown as means+ −S.E.M. The numbers of cells for each condition were as follows: KChIP1,
19 control and 17 transfected; KChIP2, 35 control and 29 transfected; KChIP3, 19 control and 21 transfected; KChIP4, 22 control and 22 transfected. * Indicates time points at which the values for
KChIP3–ECFP-transfected cells were signiﬁcantly different from control values based on use of a Student’s t test with P values less than 0.05.
study also found that overexpression of wild-type KChIP3 in
SH-SY5Y cells resulted in down-regulation of NCX3. Consistent
with these ﬁndings we found that expression of KChIP3 resulted
in a down-regulation in the levels of NCX3 but not NCX2 in
transfected PC12 cells. This ﬁnding provides an explanation for
our observations on the effects of KChIP3 expression on the
recovery of [Ca
2+]i following a Ca
2+ transient.
A stimulatory effect of KChIP3 was in response to agonist
stimulation but was not seen in permeabilized cells in response
to buffered Ca
2+ concentration suggesting that the effect was
probably related to changes in Ca
2+ signalling. The changes in
the Ca
2+ signal in response to ATP in KChIP3-expressing cells
provides an explanation for the increased secretion following
stimulation. We can rule out effects of KChIP3 via Kv4 channels
and also presenilin interactions. Trafﬁc of Kv4 channels is
stimulatedbyallfourKChIPsbutwesawnoevidencethatexpres-
sion of Kv4.2 could inﬂuence exocytosis or the enhancement due
to KChIP3 (results not shown). The interaction with presenilin
c   The Authors Journal compilation c   2008 Biochemical Society © 2008 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commerical use, distribution and reproduction in any medium, provided the original work is properly cited.78 N. Venn, L. P. Haynes and R. D. Burgoyne
Figure 6 Expression of presenilin-1–EGFP has no effect on Ca2+ concentration after stimulation with ATP or on GH release from PC12 cells
(A) PC12 cells were transfected to express presenilin-1–EGFP (PS1–EGFP) and 48h after transfection were loaded with X-rhod-1 AM and then live cells were imaged. An EGFP image was taken to
allow identiﬁcation oftransfected and non-transfectedcells and then X-rhod-1 ﬂuorescencewasmonitoredbeforeand after stimulation byperfusionwith 300μM ATP. ImagesofEGFPand X-rhod-1
before stimulation and at the peak after stimulation are shown. After completion of the experiment, average values were collected for whole-cell ﬂuorescence for transfected and adjacent control
cells. Fluorescence values were normalized to the initial ﬂuorescence for each cell and the values are shown as means+ −S.E.M. The numbers of cells for each condition were 28 for control and 26
for transfected conditions. (B) PC12 cells were transfected to express GH and presenilin-1–EGFP (PS1–EGFP) with the ECFP vector used as a control (n=18). At 2 days after transfection, the cells
were washed in Krebs–Ringer buffer and incubated with no additions (Basal) or with 300 μM ATP for 15min. GH release was assayed and expressed as a percentage of the total cellular GH levels.
(C) PC12 cells were transfected to express KChIP3 alone (a), presenilin-1–EGFP alone (b) or both proteins (c and c’). (D) PC12 cells were transfected to express GH and KChIP3–ECFP alone or in
combination with presenilin-1–EGFP (n=12). At 2days after transfection, the cells were washed in Krebs–Ringer buffer and incubated with no additions (Basal) or with 300μM ATP for 15min.
GH release was assayed and expressed as a percentage of the total cellular GH levels.
has been described not only for KChIP3 [18] but also for KChIP4
[7] and their interactions have been suggested to modify aspects
of Ca
2+ signalling [43]. However, our functional experiments
did not implicate a presenilin interaction in the KChIP3 effect
on the Ca
2+ response or secretion in PC12 cells. Expression of
KChIP3 has been reported to trigger apoptosis in HeLa cells [27],
but other KChIPs do not have this effect. Interestingly, in our
initial experiments we found that that HeLa cells transfected with
KChIP3 but not KChIPs 1, 2 and 4 failed to survive, consistent
with distinct physiological effects of these proteins. In other cell
typessuchasPC12andCOS-7cells,KChIP3doesnotappeartobe
apoptotic. There may be a link between KChIP3-speciﬁc effects
on intracellular Ca
2+ as the pro-apoptotic effect of KChIP3 has
been attributed to increased ﬁlling of EF Ca
2+ stores [33].
The down-regulation of NCX3, but not NCX1 or NCX2,
following expression of wild-type or mutant KChIP3 in other
cell types was ascribed to the DREAM transcriptional regulator
function of the protein and indeed the NCX3 gene was found to
harbour DRE motifs in its promoter region [32]. It is surprising
therefore that we observed down-regulation of NCX3 only as a
consequence of KChIP3 expression and saw no effect of KChIPs
1,2 and 4 as the DREAM activity has been suggested to be shared
by isoforms of all four KChIPs [20]. Indeed, it has been shown
thattheEF-hand-containingcoreofKChIP3issufﬁcientforCa
2+-
dependent binding to the DRE motif [44]. In addition, all four
KChIPswerefoundtobindtoDREsitesandtobeequallyefﬁcient
in repressing the transcription from three separate promoters
[20]. In contrast, the results of the present study suggest that the
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Figure 7 Effect of KChIP expression on the levels of NCX2 and NCX3 Na+/Ca2+ exchangers
(A) PC12 cells were transfected to express KChIP–ECFP constructs as indicated, ﬁxed and stained with anti-NCX2 or NCX3. Microscope ﬁelds were examined that contained both transfected cells
and non-transfected cells as seen in the ECFP images. Cells transfected with KChIP3–ECFP showing lower NCX3 immunoﬂuorescence levels are indicated by arrows. The scale bar represents
10μm. (B) Fluorescence levels from transfected and adjacent control non-transfected cells were determined (n=12) and the values for transfected cells were expressed as a percentage of the
appropriate controls. *P <0.001 compared with non-transfected control cells.
KChIPs may differentially express this function depending on the
cellular context. Although this cannot be explained on the basis
of expression levels it may be a consequence of the differential
intracellular localizations of each of the proteins determined by
elementsintheirvariableN-terminaldomainsincludingmotifsfor
myristoylation [24] and palmitoylation [45]. Further work will be
required to determine the extent to which the DREAM activity in
vivo is determined by KChIP3 alone. Overall our ﬁndings suggest
that the KChIP proteins may have a higher level of functional
specialization than had been appreciated and in particular that
differences in KChIP3 levels may speciﬁcally exert modulatory
effects on regulated secretion and possibly neurotransmission.
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